Details
Stereochemistry | ACHIRAL |
Molecular Formula | C2H7NO |
Molecular Weight | 61.0831 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NCCO
InChI
InChIKey=HZAXFHJVJLSVMW-UHFFFAOYSA-N
InChI=1S/C2H7NO/c3-1-2-4/h4H,1-3H2
Molecular Formula | C2H7NO |
Molecular Weight | 61.0831 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Monoethanolamine is both a primary amine and a primary alcohol. It is an olamine derivative. Monoethanolamine occurs in every cell in the human body as the head group of Phosphatidylethanolamine. Monoethanolamine is a component of glycosylphosphatidylinositol-anchored proteins, which are essential for viability. Other sources of monoethanolamine or phosphoethanolamine in the human body are the degradation of sphingosine phosphate by sphingosine phosphate lyase and the degradation of the endocannabinoid anandamide by the fatty acid amine hydrolase. Monoethanolamine stimulates the rapid growth of mammalian cells in culture. Monoethanolamine has a cardioprotective role against ischemia/reperfusion injury via activation of the transcription factor STAT-3. Monoethanolamine is a chemical intermediate in the manufacture of cosmetics, surface-active agents, emulsifiers, pharmaceuticals, and plasticizing agents.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1764933 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20938668 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Characterization of the lipopolysaccharide and structure of the O-specific polysaccharide of the bacterium Pseudomonas syringae pv. atrofaciens IMV 948. | 2001 Apr |
|
Concentration verification of ethanol/nitrogen compressed gas cylinders prior to use for periodic determinations of accuracy in California. | 2001 Apr |
|
Structure-activity relationship studies of (+/-)-terbutaline and (+/-)-fenoterol on beta3-adrenoceptors in the guinea pig gastric fundus. | 2001 Aug |
|
Ethanolamine transport in human placental brush-border membrane vesicles. | 2001 Aug |
|
Isothermal titration calorimetric analysis of the interaction between cationic lipids and plasmid DNA. | 2001 Feb 1 |
|
Overexpression of a mammalian ethanolamine-specific kinase accelerates the CDP-ethanolamine pathway. | 2001 Jan 19 |
|
Suicide through doxylamine poisoning. | 2001 Jun 1 |
|
Development of a serum-free medium for a human immortalized fibroblast cell line (KMST-6/TNF) producing tumor necrosis factor-alpha (TNF-alpha) and growth inhibitory effects of its conditioned medium on malignant cells in culture. | 2001 Mar |
|
Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity. | 2001 May |
|
Development of a tRNA-dependent in vitro translation system. | 2001 May |
|
Phospholipid composition of human sperm and seminal plasma in relation to sperm fertility. | 2001 May-Jun |
|
Cytoskeletal inhibitors, anti-adhesion molecule antibodies, and lectins inhibit hepatocyte spheroid formation. | 2002 Feb |
|
Saccharomonospora halophila sp. nov., a novel halophilic actinomycete isolated from marsh soil in Kuwait. | 2002 Mar |
|
Phospholipid biosynthesis in the oyster protozoan parasite, Perkinsus marinus. | 2002 May |
|
Involvement of delta-aminolaevulinate synthase encoded by the parasite gene in de novo haem synthesis by Plasmodium falciparum. | 2002 Oct 15 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20938668
Curator's Comment: Ethanolamine is a product of metabolism of sphingosine-1-phosphate (of S1P)
Rat: single injection 5 mg/kg of S1P
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28785375
1 uM of Monoethanolamine is required to activate virulence gene expression in Escherichia coli O157:H7 (EHEC), and this concentration is far below the concentration required for ethanolamine to be used as a nitrogen source.
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:19:43 GMT 2025
by
admin
on
Wed Apr 02 09:19:43 GMT 2025
|
Record UNII |
5KV86114PT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
34300-4
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
28605-4
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
26608-0
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
56678-6
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
2264-0
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
13740-6
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
NDF-RT |
N0000175814
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
NDF-RT |
N0000009905
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
15137-3
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
26593-4
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
15142-3
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
25910-1
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
EPA PESTICIDE CODE |
11601
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
NDF-RT |
N0000020024
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
49633-1
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
32239-6
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
25098-5
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
NCI_THESAURUS |
C29578
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
13613-5
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
6881-7
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
2263-2
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
25911-9
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
FDA ORPHAN DRUG |
416713
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
25405-2
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
||
|
LOINC |
26803-7
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
23981
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
DTXSID6022000
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
D019856
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
700
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
24457
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | RxNorm | ||
|
16000
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
57603
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
C61756
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
100000092555
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
SUB01990MIG
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
531
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
5KV86114PT
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
141-43-5
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
ETHANOLAMINE
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
205-483-3
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
CHEMBL104943
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
5KV86114PT
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
DB03994
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
m5052
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | Merck Index | ||
|
1445925
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY | |||
|
497
Created by
admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (GC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|